Therapeutics - Arrhythmias Part 2 Flashcards
(47 cards)
2 goals for rhythm control for afib
get to NSR
reduce patient’s symptoms
what is an “acute transition to NSR”
a cardioversion
2 general methods for rhythm control for afib
cardioversion or chronic meds
which 2 rhythm control drugs use the “pill in pocket” approach
flecainide, propafenone
the choice of anti arrhythmics for afib is severely limited by what
any heart disease
ONLY TWO antiarrhythmics that can be given to afib patients who also have MI, HF, or other structural heart disease
amiodarone, sotalol
general guideline on when to give anti ARRHYTHMICS for afib
if had afib for less than a year (if over a year – very hard to get back to normal sinus rhythm)
if the pt has concurrent heart failure
pt has persistent symptoms while on rate control
they are hemodynamically unstable
dose of flecainide/propafenone for pill in pocket approach
flecainide - 200-300mg once
propafenone - 450-900mg once
explain what the “pill in pocket” approach exactly is
patients self administered a dose when they feel symptoms
has been shown to reduce hospital admissions and costs - improved qol
HOWEVER, the patient must first be on an AV nodal blocking agent (otherwise, this approach can cause rapid av conduction and atrial flutter)
sotalol contraindication
in creatinine clearance less than 40ml!
important monitoring parameter for sotalol (anti-arrhytmic)
monitor QT!!!!! for initial 3 days, and then every 3-6 months
patient’s creatinine clearance is 40-60mL/min
what is sotalol dosing
once a day
if below 40 - contraindicated!
true or false
amiodarone is very effective at maintaining normal sinus rhythm
true
monitoring recommendations for amiodarone ADRs
baseline: chest xray, liver fxn test, EKG
repeat TSH and liver fxn every 6 months
repeat EKG and physical every year
loading and maintenance dosing amiodarone
loading - total - 6-10g (400-800mg daily in 2-4 doses) - big dose 1st so it starts working
maintenance is 200mg QD
haloperidol + amiodarone
risk torsada
methadone + amiodarone
risk torsada
dofetilide brand
tikosyn
concern with dofetilide
risk for serious ventricular arrhythmias!!!
contraindication to dofetlilide
creatinine clearance less than 20
explain when dofetilide should be initiated and the monitoring parameters
initiate inpatient for 3 days – monitor EKG! for QT!
then monitor EKG every 3-6 months
dronedarone brand name
multaq
multaq (dronedarone) dosing
500mcg BID (adjust for renal)
differentiate between dronedarone and amiodarone
dronedarone has a shorter half life, no iodine, and less noncardiac toxicities
HOWEVER, it is also less effective, increases serum creatinine, AND has an FDA warning of acute hepatic failure